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ABSTRACT: The histidine-tagged secondary multidrug transporter LmrP was overexpressed in Lactococcus
lactis, using a novel protein expression system for cytotoxic proteins based on the tightly regulated, nisin-
inducible nisA promoter. LmrP-mediated H+/drug antiport activity in inside-out membrane vesicles was
inhibited by detergents, such as Triton X-100, Triton X-114, and Tween 80, at low concentrations that
did not affect the magnitude or composition of the proton motive force. The inhibition of the activity of
LmrP by detergents restricted the range of compounds that could be used for the solubilization and
reconstitution of the protein because low concentrations of detergent are retained in proteoliposomes.
Surprisingly, dodecyl maltoside did not modulate the activity of LmrP. Therefore, LmrP was solubilized
with dodecyl maltoside, purified by nickel-chelate affinity chromatography, and reconstituted in dodecyl
maltoside-destabilized, preformed liposomes prepared from Escherichia coli phospholipids and egg
phosphatidylcholine. Reconstituted LmrP mediated the transport of multiple drugs in response to an
artificially imposed pH gradient, demonstrating that the protein functions as a proton motive force-dependent
multidrug transporter, independent of accessory proteins. These observations are relevant for the effective
solubilization and reconstitution of multidrug transporters belonging to the major facilitator superfamily,
which, in view of their broad drug specificity, may strongly interact with detergents.
The emergence of multidrug resistance (MDR)1 poses a
serious threat to public health. The active extrusion of drugs
out of cells is one of the major causes of failure of
chemotherapy in the treatment of cancer (1). Like cancer
cells, microorganisms can develop resistance by the energy-
dependent extrusion of toxic compounds from the cell (2).
These drug efflux processes are mediated by transport
proteins, which can be relatively specific for a given substrate
or can handle a wide variety of structurally unrelated
compounds (3-6). Although some bacterial transporters
utilize the free energy of ATP hydrolysis to extrude cytotoxic
compounds (7-9), most bacterial multidrug efflux systems,
known to date, are driven by the proton motive force (5).
These secondary transporters can be subdivided on the basis
of size and similarities in the primary and putative secondary
structures. Members of the major facilitator superfamily
(MFS) (10) and the resistance/nodulation/cell division family
(RND) (11) are integral membrane proteins with 12 or 14
transmembrane segments and a molecular mass of 45-50
kDa. Members of the small multidrug resistance (SMR)
family are functionally similar to MDR transporters from
the MFS and RND families, but they only contain four
putative transmembrane R-helices (12, 13).
In the Gram-positive bacterium Lactococcus lactis, at least
four extrusion activities have been detected (6, 14-16). Pmf-
dependent drug resistance is conferred by the lmrP gene,
which encodes a hydrophobic polypeptide of 408 amino acid
residues with 12 putative membrane-spanning segments (17).
LmrP-mediated transport of TPP+ in Escherichia coli
membrane vesicles is driven by the membrane potential (¢ª)
and the transmembrane proton gradient (¢pH), which is
indicative of an electrogenic nH+/drug (n g 2) antiport
mechanism. Molecular characterization of LmrP-dependent
transport of the fluorescent membrane probe TMA-DPH
demonstrated a relation between the transport rate and the
amount of TMA-DPH associated with the inner leaflet of
the lipid bilayer, providing evidence for the active removal
of the probe from the cytoplasmic membrane (18).
In this paper, we have used the tightly regulated nisA
promoter to overexpress LmrP in L. lactis with the aim of
purifying and constituting the protein in proteoliposomes.
To our knowledge, the only secondary MDR transporters
that have been reconstituted so far are the SMR members
EmrE from E. coli (12) and Smr from Staphyllococcus
aureus (19). Surprisingly, Smr members can be quantitatively
extracted with organic solvents such as chloroform/methanol,
and are pure and stable after this extraction. For LmrP, the
purification and reconstitution of the protein required the use
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of detergents. Our studies show that low concentrations of
detergents Triton X-100, Triton X-114, and Tween 80 already
inhibit LmrP-mediated transport, which posed problems in
the development of purification and reconstitution proce-
dures. Dodecyl maltoside did not modulate the activity of
LmrP at low concentrations, and was used to efficiently
solubilize LmrP from L. lactis membranes. The C-terminal
His-tagged protein was purified by nickel-chelate affinity
chromatography and functionally incorporated into dodecyl
maltoside-saturated, preformed liposomes. To our knowledge,
this work represents the first report on the functional
reconstitution of a multidrug transporter of the MFS family.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions. Bacterial strains
and plasmids used in this study are listed in Table 1. L. lactis
strains were grown at 30 °C in M17 medium (Difco)
supplemented with 0.5% glucose (w/v) and 5 íg/mL
chloramphenicol when appropriate.
DNA Manipulations and Plasmid Constructions. General
procedures for cloning and DNA manipulations were per-
formed as described by Sambrook et al. (20). The 2128 bp
NcoI-SacI fragment of plasmid pSKoppAChis was ligated
into the NcoI-SacI sites of the nisin-inducible vector
pNZ8048, yielding the expression vector pNZ8048oppAChis
(Table 1).
A NcoI restriction site at the ATG start codon of the lmrP
gene and a BamHI restriction site that overlaps with the stop
codon of lmrP were introduced by the polymerase chain
reaction, using the primers GGGGCCATGGGGAAA-
GAGTTTTGGAATTTA and GGGGGGATCCATTTAATTT-
GTTTTC, and chromosomal DNA of L. lactis MG1363 as
a template. The PCR product was digested with NcoI and
BamHI, and ligated with the 3.7 kb vector fragment obtained
by digestion of pNZ8048oppAChis with NcoI and BamHI.
The lmrP coding sequence in the resulting plasmid pHLP5
was sequenced to ensure that only the intended changes had
been introduced.
Preparation of Membrane Vesicles. L. lactis NZ9000
harboring either pNZ8048 or pHLP5 was grown at 30 °C to
an A660 of about 0.5, after which a 1:1000 dilution of NZ9700
supernatant, containing approximately 10 ng of nisin A/mL
(O. Kuipers, personal communication), was added to trigger
transcription from the nisA promoter. Following incubation
for an additional 1 h at 30 °C, the cells were harvested by
centrifugation. For the isolation of inside-out membrane
vesicles, cells were lysed by a 2-fold passage through a
French pressure cell, after digestion of the cell wall with 10
mg/mL lysozyme (incubation for 20 min at 30 °C). The crude
membranes were incubated for 30 min at 30 °C with 10 mM
MgSO4 and 100 íg/mL DNase, and unbroken cells and cell
debris were removed by centrifugation at 13000g for 10 min
at 4 °C. Subsequently, the inside-out membrane vesicles were
collected from the supernatant by centrifugation at 125000g
for 1 h at 4 °C. The membrane vesicles were resuspended
in 50 mM potassium phosphate (pH 7.0) containing 10%
(v/v) glycerol and stored in liquid nitrogen.
For the estimation of LmrP expression levels, peripheral
membrane proteins as well as cytosolic contaminants were
extracted with 5 M urea and 6% (w/v) sodium cholate as
described previously (21). Protein was assayed according to
the method of Lowry et al. (22) in the presence of 0.5%
SDS, using bovine serum albumin as a standard.
Measurement of the ¢pH in Membrane Vesicles. The ¢pH
in inside-out membrane vesicles was monitored by fluores-
cence quenching of Acridine orange (23). Membrane vesicles
(0.5 mg of protein/mL) were resuspended in 50 mM
potassium Hepes (pH 7.0) containing 2 mM MgSO4, 8.5 mM
NaCl, 0.1 mg/mL creatine kinase, and 5 mM phosphocre-
atine. Acridine orange was added at a final concentration of
1.25 íM. Upon the addition of 0.5 mM Mg2+-ATP, a pmf
(interior positive and acid) was generated by the F0F1 H+-
ATPase. The ionophores valinomycin and nigericin were
added to a final concentration of 1 íM each, to dissipate the
¢ª and ¢pH, respectively. Acridine orange fluorescence was
monitored at 30 °C, in a Perkin-Elmer LS-50B fluorimeter,
using excitation and emission wavelengths of 494 and 530
nm, respectively, with slit widths of 3 nm each.
Preparation of Liposomes. The E. coli total lipid extract
(Avanti Polar Lipids) was acetone/ether washed as described
by Viitanen et al. (24), dissolved in chloroform, and stored
at -20 °C under N2. For the preparation of liposomes, the
E. coli lipids and egg yolk phosphatidylcholine (Avanti Polar
Lipids) in a 3:1 ratio (w/w) were evaporated to dryness under
vacuum using a rotary evaporator. The lipids were resus-
pended in 50 mM potassium phosphate (pH 7.0) at a
concentration of 20 mg/mL, using a syringe equipped with
a 0.55 mm  250 mm hypodermic needle. The suspension
was sonicated under N2, on ice, using a tip sonicator at an
intensity of 4 ím (peak to peak) for four cycles with intervals
of 15 s of sonication and 45 s of rest. Samples of 1 mL
were frozen in liquid N2 and slowly thawed at room
temperature. This freeze-thaw step was repeated once, and
the liposomes were stored in liquid N2.
Solubilization. Membrane vesicles (1-4 mg of membrane
protein) from L. lactis NZ9000 harboring pHLP5 were
solubilized in 50 mM potassium phosphate (pH 8.0) contain-
ing 100 mM NaCl, 10% (v/v) glycerol, and 1% (w/v)
Table 1: Bacterial Strains and Plasmids
relevant properties reference
strain
MG1363 plasmid-free and prophage-cured derivative of NCDO 712 35
NZ9000 MG1363 derivative, pepN::nisRK O. Kuipers, unpublished
NZ9700 nisin-producing transconjugant containing TN5276 36
NZ9800 NZ9700 derivative, ¢nisA 36
plasmid
pNZ8048 CmR, pSH71 replicon, inducible nisA promoter O. Kuipers, unpublished
pSKoppAChis pSKII+ carrying His-tagged OppA of L. lactis Picon et al., in preparation
pNZ8048oppAChis pNZ8048 carrying His-tagged OppA of L. lactis this work
pHLP5 pNZ8048 carrying His-tagged LmrP of L. lactis this work
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detergent. The suspensions were mixed and incubated on ice
for 30 min. The insoluble material was pelleted by centrifu-
gation (280000g for 20 min at 4 °C). The amount of His-
tagged LmrP in the soluble and insoluble fractions was
quantified by immunoblotting as described previously (25)
using monoclonal anti His-tag antibody DIA 900 (Dianova).
Purification and Reconstitution of LmrP. His-tagged LmrP
was purified by affinity chromatography using Ni2+-
nitrilotriacetic acid (Ni-NTA)-agarose (Qiagen Inc.). The
solubilized membrane proteins were mixed with Ni-NTA
resin (25 íL of resin/mg of protein), which was equilibrated
with 50 mM potassium phosphate (pH 8.0) supplemented
with 100 mM NaCl, 10% (v/v) glycerol, 0.2 mg/mL E. coli
lipids, 0.05% detergent (buffer A), and 10 mM imidazole,
and gently shaken for 60 min at 4 °C. The resin was
transferred to a Bio-spin column (Bio-Rad) and subsequently
washed with 20 column volumes of buffer A and 10 mM
imidazole and 10 column volumes of buffer A and 20 mM
imidazole. The protein was eluted with buffer A (pH 7.0)
containing 250 mM imidazole, and fractions of 500 íL were
collected. The fractions were analyzed by SDS-PAGE (26).
For membrane reconstitution of LmrP, the liposomes were
slowly thawed and extruded (11 times) through a 400 nm
polycarbonate filter to obtain unilamellar liposomes with a
relatively homogeneous size. Subsequently, the liposomes
were diluted to 4 mg of lipid/mL and saturated with
detergent, which was followed by measuring the A540, as
described by Paternostre et al. (27). The purified LmrP
protein was mixed with the detergent-saturated liposomes
(1 ímol of dodecyl maltoside/mg of lipid) at a protein:lipid
ratio of 1:150 (w/w) and incubated for 30 min at room
temperature under gentle agitation. The detergent was
removed by absorption to polystyrene beads as described
previously (25). Finally, the proteoliposomes were collected
by centrifugation (280000g for 20 min at 4 °C), resuspended
in 20 mM potassium phosphate (pH 7.0) supplemented with
100 mM KAc and 2 mM MgSO4, and stored in liquid
nitrogen.
Transport Assays
Intact Cells. For the transport of ethidium bromide (17),
cells were washed and resuspended in 50 mM potassium
phosphate (pH 7.0) containing 5 mM MgSO4. Glucose (25
mM) was added to supply the cells with metabolic energy.
Membrane Vesicles. To study transport of Hoechst 33342
(Molecular Probes Inc.) by LmrP, inside-out membrane
vesicles (0.5 mg of protein/mL) were resuspended in 50 mM
potassium Hepes (pH 7.0) containing 2 mM MgSO4, 8.5 mM
NaCl, 0.1 mg/mL creatine kinase, and 5 mM phosphocre-
atine. After incubation for 30 s at 30 °C, Hoechst 33342
was added at 1 íM (final concentration). LmrP was activated,
following the generation of a pmf by the F0F1 H+-ATPase,
upon the addition of 0.5 mM Mg2+-ATP. The amount of
membrane-associated Hoechst 33342 was measured fluori-
metrically (Perkin-Elmer LS 50B fluorometer), using excita-
tion and emission wavelengths of 355 and 457 nm, respec-
tively, and slit widths of 5 nm.
Proteoliposomes. Hoechst 33342 transport in proteolipo-
somes was driven by an artificially imposed proton gradient
(alkaline inside). The frozen proteoliposomes, in 20 mM
potassium phosphate (pH 7.0), 100 mM KAc, and 2 mM
MgSO4 (buffer B), were thawed undisturbed at room
temperature, extruded (11 times) through a 400 nm poly-
carbonate filter, collected by centrifugation (280000g for 20
min at 4 °C), and resuspended to a final concentration of
0.4 mg of protein/mL in buffer B. A 5 íL sample was diluted
100-fold into 20 mM potassium phosphate (pH 7.0) contain-
ing 50 mM K2SO4 and 2 mM MgSO4. After 20 s, Hoechst
33342 in water was added at a final concentration of 1 íM;
other additions were made as described in the figure legends.
RESULTS
OVerexpression of Functional Histidine-Tagged LmrP in
L. lactis. In a previous study, LmrP was heterologously
expressed in E. coli strain DH5R, using the IPTG-inducible
trc promoter (18). It was observed that the E. coli cells
stopped growing upon induction of LmrP expression, even
though the expression levels were maximally only 0.1% of
the total amount of the membrane protein. We therefore
switched to a homologous expression system that takes
advantage of the nisin-inducible, tightly regulated nisA
promoter (28). The lmrP gene was inserted into pNZ8048,
yielding pHLP5. To facilitate the purification of LmrP, a
factor Xa cleavage site and a six-histidine tag were intro-
duced at the C-terminus of the protein.
Energized L. lactis NZ9000/pHLP5 cells, overexpressing
LmrP, showed strongly reduced uptake of ethidium (Figure
1A). This observation indicates that the histidine-tagged
LmrP protein is functional. In addition, Hoechst 33342
transport studies were performed using inside-out membrane
vesicles. Hoechst 33342, a substrate of various MDR
transporters, including LmrP (29, 30), is strongly fluorescent
in a hydrophobic environment, and essentially nonfluorescent
in an aqueous environment. Therefore, a decrease in fluo-
rescence upon activation of LmrP corresponds with a net
movement of Hoechst 33342 from the membrane to the
aqueous phase. Figure 1B demonstrates that LmrP efficiently
expels Hoechst 33342 LmrP from the NZ9000/pHLP5
membranes upon the generation of a pmf. The residual
Hoechst 33342 efflux activity, which is observed in NZ9000/
pNZ8048 membrane vesicles (Figure 1B, dotted line), is most
likely mediated by endogenous, chromosomally encoded
LmrA, LmrP, and/or other drug efflux activities. When both
the membrane potential (¢ª) and the transmembrane proton
gradient (¢pH) were dissipated by the addition of the
ionophores valinomycin and nigericin, LmrP-mediated drug
transport was inhibited and Hoechst 33342 fluorescence
increased to the level observed with control membrane
vesicles. To quantitate the level of expression of LmrP,
inside-out membrane vesicles of L. lactis NZ9000/pHLP5,
extracted with 5 M urea/6% (w/v) sodium cholate, were
analyzed by SDS-PAGE and stained with Coomassie
Brilliant Blue (Figure 1C, lane 2). The level of LmrP was
estimated to be 5% of the total amount of integral membrane
protein.
Effect of Detergents on LmrP ActiVity. Bolhuis et al. (18)
provided evidence for transport of TMA-DPH by LmrP from
the inner leaflet of the cytoplasmic membrane. Other
amphiphilic compounds that partition in the membrane may
be recognized by LmrP in a similar fashion. Thus, the
detergents used in the purification and reconstitution of
membrane proteins are potential substrates of LmrP. The
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ability of octyl glucoside, C10E8, C12E8, decyl maltoside,
dodecyl maltoside, Tween 20, Tween 80, Triton X-100,
Triton X-114, and SDS to compete with Hoechst 33342 for
LmrP-mediated transport in inside-out membrane vesicles
was tested. Figure 2A shows that energy-dependent Hoechst
33342 transport in inside-out membrane vesicles was sig-
nificantly inhibited by Triton X-100. Similar results were
obtained for Triton X-114 and Tween 80. A concentration
of 0.005% (w/v) Triton X-100, Triton X-114, or Tween 80
resulted in 46, 36, and 24% inhibition of the initial rate of
Hoechst 33342 transport, respectively. The fluorescent probe
Acridine orange was used to study the effect of the detergents
on the pmf (Figure 2B). Generation of a ¢pH (inside acid)
causes quenching of Acridine orange fluorescence. Upon
addition of valinomycin, the fluorescence further decreases,
due to the interconversion of ¢ª into ¢pH. The subsequent
dissipation of the pH gradient, by the addition of nigericin,
leads to the release of Acridine orange from the vesicles,
C
FIGURE 1: Overexpression of His-tagged LmrP in L. lactis. (A)
Ethidium accumulation in L. lactis NZ9000/pNZ8048 (control cells,
dotted line) and NZ9000/pHLP5 (LmrP-expressing cells, solid line).
Cells (a) were incubated for 1 min in 50 mM potassium phosphate
(pH 7.0) supplemented with 5 mM MgSO4 and 25 mM glucose.
The assay was started upon addition of 10 íM ethidium bromide
(b) to the cell suspension. (B) Inside-out membrane vesicles
prepared from control cells (dotted line) and LmrP-expressing cells
(solid line) were diluted to a concentration of 0.5 mg of protein/
mL in 50 mM potassium Hepes (pH 7.0) containing 2 mM MgSO4,
8.5 mM NaCl, 0.1 mg/mL creatine kinase, and 5 mM phospho-
creatine. After incubation for 30 s, 1 íM Hoechst 33342 was added
(a). Transport was initiated upon addition of 0.5 mM Mg2+-ATP
(b). Valinomycin (c) and nigericin (d) were added to a final
concentration of 1 íM each. (C) Coomassie Brilliant Blue-stained
SDS-PAGE gel (10%) with samples of urea/cholate extracted
inside-out membrane vesicles prepared from L. lactis NZ9000/
pNZ8048 (control cells, lane 2) or NZ9000/pHLP5 (LmrP-express-
ing cells, lane 3). Molecular weight markers are shown in lane 1.
The arrow indicates the position of the His-tagged LmrP protein.
FIGURE 2: Effect of Triton X-100 on Hoechst 33342 transport and
proton motive force generation in inside-out membrane vesicles.
(A) Inhibition of Hoechst 33342 transport in membrane vesicles
by Triton X-100. The rate of Hoechst 33342 transport (as described
in the legend of Figure 1) was measured in the presence (solid
line) or absence (dotted line) of 0.005% (w/v) Triton X-100. The
addition of 1 íM Hoechst 33342 (a) and 0.5 mM Mg2+-ATP (b)
are indicated. (B) Measurement of the ¢pH (interior acid) in
membrane vesicles, in the presence (solid line) or absence (dotted
line) of 0.005% (w/v) Triton X-100. For clarity of presentation,
the solid trace is offset 50 units from the dotted trace. Acridine
orange was added to a final concentration of 1.25 íM (a). A proton
motive force (interior acid and positive) was generated by the F1F0
H+-ATPase upon the addition of 0.5 mM Mg2+-ATP (b). Valino-
mycin (c) and nigericin (d) were added to a final concentration of
1 íM each, to interconvert ¢ª into ¢pH, and to dissipate the ¢pH,
respectively.
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with a concomitant increase in fluorescence (23). This
increase is indicative for the magnitude of the pmf that was
generated. The Acridine orange measurements revealed that,
at the concentrations used, the detergents did not affect the
magnitude and composition of the pmf. These results imply
that Triton X-100, Triton X-114, and Tween 80 affect LmrP
directly, either by competing with the substrate for LmrP-
mediated transport or by modulating the LmrP activity
otherwise. In view of the retention of detergents in procedures
aimed at the incorporation of proteins into artificial mem-
branes (31; J. Knol et al., in preparation), Triton X-100,
Triton X-114, and Tween 80 are not suitable for reconstitu-
tion of LmrP.
Solubilization of LmrP from Inside-Out Membrane Vesicles.
Various detergents were evaluated for their efficiency to
solubilize LmrP from inside-out membrane vesicles. Figure
3 shows that octyl glucoside, C10E8, and C12E8 solubilized
only 70% of LmrP from NZ9000/pHLP5 membranes. Better
results were obtained with the detergents Triton X-100, decyl
maltoside, and dodecyl maltoside, which solubilized more
than 90% of the LmrP. Analysis of the protein samples on
SDS-PAGE showed that solubilization with Triton X-100,
octyl glucoside, C10E8, and C12E8 resulted in the formation
of relatively large amounts of di- and trimeric structures
(Figure 3, lanes As, Bs, Es, and Fs). Therefore, dodecyl
maltoside was chosen for the purification of LmrP.
Purification. The solubilized membrane proteins from L.
lactis NZ9000 harboring pNZ8048 or pHLP5 were applied
to a nickel chelate affinity resin, and contaminating proteins
were removed by washing the column with 10 and 20 mM
imidazole. LmrP was eluted by lowering the pH of the buffer
to 7.0 and increasing the imidazole concentration to 250 mM.
FIGURE 3: Solubilization of LmrP from inside-out membrane
vesicles of L. lactis NZ9000/pHLP5. Membranes (1 mg of protein)
were solubilized in 50 mM potassium phosphate (pH 8.0) supple-
mented with 100 mM NaCl, 10% (v/v) glycerol, and 1% (w/v)
detergent: (A) Triton X-100, (B) octyl glucoside, (C) decyl
maltoside, (D) dodecyl maltoside, (E) C10E8, and (F) C12E8. The
suspensions were mixed and incubated on ice for 30 min. The
insoluble material was pelleted by centrifugation (280000g for 20
min at 4 °C), and the soluble (s) and insoluble (i) fractions were
analyzed by SDS-PAGE and immunoblotting using monoclonal
antibodies directed against the histidine tag.
FIGURE 4: Purification of the histidine-tagged LmrP protein. Silver-
stained SDS-PAGE gel (10%) with samples from NZ9000/
pNZ8048 (lanes 1, 3, and 5) and NZ9000/pHLP5 (lanes 2, 4, and
6): total membranes (lanes 1 and 2), supernatant (20 min at
280000g) after solubilization with 1% (w/v) dodecyl maltoside
(lanes 3 and 4), and Ni-NTA eluates at 250 mM imidazole (lanes
5 and 6). The molecular weight markers are shown in lane 7. The
arrow indicates the position of the His-tagged LmrP protein.
FIGURE 5: Hoechst 33342 transport in proteoliposomes. Proteoli-
posomes were loaded with 20 mM potassium phosphate (pH 7.0)
containing 100 mM potassium acetate and 2 mM MgSO4. Hoechst
33342 (a) and nigericin (b) were added to final concentrations of
1 íM each. The fluorescence intensity after addition of nigericin
was normalized to 100%. (A) Hoechst 33342 fluorescence for
liposomes containing LmrP (solid line) and control liposomes
(dotted line), in which an artificial ¢pH (interior alkaline) was
imposed by a 100-fold dilution of the proteoliposomes into 20 mM
potassium phosphate (pH 7.0) containing 50 mM K2SO4 and 2 mM
MgSO4. (B) ¢pH (interior alkaline)-driven, LmrP-mediated Hoechst
33342 transport in proteoliposomes in the absense (solid line) and
presence of 20 íM erythromycin (dotted line).
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LmrP was purified in a single step to a high degree of purity
(>90%). Besides a major band at 36 kDa, minor bands were
found at 62 and 102 kDa (Figure 4, lane 6). Western blot
analysis, using monoclonal anti His-tag antibodies, showed
that these bands represent di- and trimeric species of LmrP
(data not shown). The absorption spectrum of the purified
protein showed very little absorbance in the 320-340 nm
range, indicating that higher-order aggregates of LmrP are
not formed in the solubilization or purification steps (data
not shown). Approximately 1 mg of purified LmrP was
obtained from 1 L of L. lactis NZ9000/pHLP5 grown to an
A660 of 0.7-0.9.
Reconstitution. LmrP was reconstituted by mixing the
purified protein with preformed dodecyl maltoside-destabi-
lized liposomes, composed of E. coli phospholipids and egg
phosphatidylcholine in a 3:1 ratio, followed by the slow
removal of detergent. Treatment of liposomes with detergent
was followed by measuring the A540 (25, 27). The onset of
solubilization (liposomes saturated with detergent) was
reached at a concentration of 1 ímol of dodecyl maltoside/
mg of lipid (data not shown), and this detergent concentration
was used to reconstitute purified LmrP (100 íg) at a protein:
lipid ratio of 1:150 (w/w). After removal of the detergent
by absorption to polystyrene beads (Biobeads SM-2) and a
freeze-thaw step, the sample was extruded through a 400
nm polycarbonate filter to obtain unilamellar proteoliposomes
with a relatively homogeneous size.
The Hoechst 33342 transport assay was used to assess the
transport activity of membrane-reconstituted LmrP. When
an artificial proton gradient was imposed, the Hoechst 33342
fluorescence of LmrP-containing liposomes decreased in time
(Figure 5A). Following the dissipation of ¢pH by the
addition of nigericin, Hoechst 33342 fluorescence of the
LmrP-containing liposomes increased to the initial level,
demonstrating that the LmrP-mediated Hoechst 33342 trans-
port was ¢pH-dependent. Hoechst 33342 transport was not
observed in liposomes lacking LmrP or in LmrP-containing
proteoliposomes in the absence of a ¢pH (data not shown).
Furthermore, addition of the LmrP substrate erythromycin
resulted in inhibition of the LmrP-mediated Hoechst 33342
transport in proteoliposomes (Figure 5B).
DISCUSSION
The nisin-controlled gene expression system (NICE), based
on the L. lactis nisA promoter (28), was used for amplified
expression of LmrP. Nisin induces transcription from the nisA
promoter via a two-component regulatory system that is
composed of the nisin sensor NisK and the transcription
factor NisR (32). The nisA promoter is more tightly regulated
than other promoters, which offers the advantage of over-
expressing toxic proteins in L. lactis (28). In the absence of
nisin, we did not observe detectable amounts of LmrP in L.
lactis. Upon induction, the level of LmrP expression in L.
lactis was approximately 5% of the total amount of integral
membrane protein. Ethidium uptake was significantly re-
duced in L. lactis cells overexpressing LmrP, demonstrating
that the protein is functional.
Since Hoechst 33342 is highly fluorescent in a hydropho-
bic environment and not in a hydrophilic environment, the
probe proved to be very suitable for studying its transport
from the lipid to the aqueous phase. Hoechst 33342 has also
successfully been used in studies of reconstituted P-glyco-
protein (29). Our study showed that Hoechst 33342 is
transported by LmrP, in both inside-out membrane vesicles
and proteoliposomes. The artificially imposed proton gradient
was large and stable enough to drive Hoechst 33342 transport
by the reconstituted LmrP. The observed LmrP-mediated
Hoechst 33342 transport in proteoliposomes is much slower
than that observed in inside-out membrane vesicles. Similar
observations were made by Shapiro et al. (29, 30) for
reconstituted P-glycoprotein. It was speculated that the high
lipid:protein ratio in proteoliposomes allows a higher rate
of passive rebinding of transported Hoechst 33342 to the
membrane, as compared to native membranes, which results
in a lower net rate of drug transport. In addition, the rate of
drug extrusion by purified MDR transport proteins may be
affected by the significant retention of detergent during the
reconstitution procedures (approximately 1 mol of dodecyl
maltoside per 15-20 mol of phospholipid; J. Knol et al., in
preparation). The detergent may affect the passive flip-flop
of the drug from one leaflet to the other and thereby interfere
with net drug transport indirectly. Due to their amphiphilic
character, detergents are potential substrates of drug trans-
porters. This aspect is particularly relevant for those trans-
porters that are able to accept their substrates from the
membrane phase, as was shown for TMA-DPH extrusion
by LmrP (18). For LmrP, it was observed that Triton X-100,
Triton X-114, and Tween 80 inhibit Hoechst 33342 transport
in inside-out membrane vesicles at low concentrations that
do not affect the magnitude or composition of the proton
motive force, whereas decyl maltoside, dodecyl maltoside,
octyl glucoside, C10E8, C12E8, and Tween 20 do not inhibit
LmrP activity. Thus, the choice of detergent for solubilization
and reconstitution of MDR transporters may be crucial for
activity measurements of the purified proteins in proteoli-
posomes. In previous work, Van Helvoort et al. (33) and
Bosch et al. (34) demonstrated that phosphatidylcholine and
phosphatidylethanolamine are potential substrates for the
human multidrug transporter P-glycoprotein. Therefore,
similar considerations may have to be made for the choice
of lipids used for the reconstitution of secondary multidrug
transporters.
Taken together, the results obtained in this work with
purified LmrP reconstituted into proteoliposomes demon-
strate that LmrP by itself is capable of mediating drug
transport without accessory proteins or cytosolic components.
The modulation of the activity of LmrP by detergents restricts
the range of compounds that can be used for solubilization
and reconstitution protocols.
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